The new test detects up to 250 viruses and bacteria, including SARS-CoV-2, influenza, Bordetella pertussis, and RSV, in a single patient sample. Rapid results enable doctors to make fast, confident ...

Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the ...

Infectious diseases caused by diverse pathogens—including viruses, bacteria, and fungi—pose a significant diagnostic challenge, especially when conventional assays fail to identify the causative ...

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for its NxTAG® Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory ...

Specimen Identification Label tube with patient's first and last name, DOB and date/time of collection. Special Instructions Swab should be transferred to 1-3 ml of viral transport medium as soon as ...

Respiratory pathogens are a significant source of global morbidity, mortality, and economic burden, with the COVID-19 pandemic driving increased interest in and funding for respiratory disease ...

QIAGEN N.V. and Celera Corporation have announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN’s ResPlex II ...

Pediatric respiratory testing rates increased significantly during the COVID-19 pandemic, with sustained high levels through 2023. Testing was more frequent in children with complex chronic conditions ...

The COVID-19 pandemic brought the term "Polymerase Chain Reaction testing" into the mainstream. The PCR method is a type of nucleic acid amplification test (NAAT) that detects a pathogen by finding ...